2013

Murphy, A., Fenwick, E., Toff, W.D., Neilson, M.P., Berry, C., Uren, N., Oldroyd, K.G., and Briggs, A.H. (2013) Transcatheter aortic valve implantation for severe aortic stenosis: the cost-effectiveness case for inoperable patients in the United Kingdom. International Journal of Technology Assessment in Health Care, 29 (01). pp. 12-19. ISSN 0266-4623 (doi:10.1017/S0266462312000670)

Boyd, K., and Briggs, A. (2013) Statistical issues with trial data and economic modeling for cost-effectiveness evaluation. In: Tang, W. and Tu, X. (eds.) Modern Clinical Trial Analysis. Series: Applied bioinformatics and biostatistics in cancer research . Springer-Verlag, New York, NY, USA, pp. 149-166. ISBN 9781461443216

Grutters, J.P.C., Sculpher, M., Briggs, A.H., Severens, J.L., Candel, M.J., Stahl, J.E., de Ruysscher, D., Boer, A., Ramaekers, B.L.T., and Joore, M.A. (2013) Acknowledging patient heterogeneity in economic evaluation. PharmacoEconomics, 31 (2). pp. 111-123. ISSN 1170-7690 (doi:10.1007/s40273-012-0015-4)

Tigbe, W.W., Briggs, A.H., and Lean, M.E.J. (2013) A patient-centred approach to estimate total annual healthcare cost by body mass index in the UK Counterweight programme. International Journal of Obesity . ISSN 0307-0565 (doi:10.1038/ijo.2012.186) (In Press)

2012

Geue, C., Lewsey, J., Lorgelly, P., Govan, L., Hart, C., and Briggs, A. (2012) Spoilt for choice: implications of costing hospital episode statistics. Health Economics, 21 (10). pp. 1201-1216. ISSN 1057-9230 (doi:10.1002/hec.1785)

Briggs, A.H., Weinstein, M.C., Fenwick, E.A.L., Karnon, J., Sculpher, M.J., and Paltiel, A.D. (2012) Model parameter estimation and uncertainty: a report of the ISPOR-SMDM modeling good research practices task force-6. Value in Health, 15 (6). pp. 835-842. ISSN 1098-3015 (doi:10.1016/j.jval.2012.04.014)

Caro, J.J., Briggs, A.H., Siebert, U., and Kuntz, K.M. (2012) modeling good research practices—overview: a report of the ISPOR-SMDM modeling good research practices task force-1. Value in Health, 15 (6). pp. 796-803. ISSN 1098-3015 (doi:10.1016/j.jval.2012.06.012)

Wu, O., Briggs, A., and MacIntyre, K. (2012) Mobile phone use for contacting emergency services in life-threatening circumstances. Journal of Emergency Medicine, 42 (3). pp. 291-298. ISSN 0736-4679 (doi:10.1016/j.jemermed.2011.02.022)

Briggs, A. (2012) The ends justify the mean: outcome measures for estimating the value of new cancer therapies. Health Outcomes Research in Medicine, 3 (1). e25-e26. ISSN 1877-1319 (doi:10.1016/j.ehrm.2012.01.001)

Briggs, A.H., Weinstein, M.C., Fenwick, E.A.L., Karnon, J., Sculpher, M.J., and Paltiel, A.D. (2012) Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM modeling good research practices task force working group - 6. Medical Decision Making, 32 (5). pp. 722-732. ISSN 0272-989X (doi:10.1177/0272989X12458348)

Caro, J.J., Briggs, A.H., Siebert, U., and Kuntz, K.M. (2012) Modeling good research practices - overview: a report of the ISPOR-SMDM modeling good research practices task force - 1. Medical Decision Making, 32 (5). pp. 667-677. ISSN 0272-989X (doi:10.1177/0272989X12454577)

Govan, L. et al. (2012) The effect of deprivation and HbA1c on admission to hospital for diabetic ketoacidosis in type 1 diabetes. Diabetologia, 55 (9). pp. 2356-2360. ISSN 0012-186X (doi:10.1007/s00125-012-2601-6)

Roberts, N.J., Boyd, K., Briggs, A.H., Caress, A.L., and Partridge, M.R. (2012) Nurse led versus lay educators support for those with asthma in primary care: a costing study. BMC Pulmonary Medicine, 12 (52). ISSN 1471-2466 (doi:10.1186/1471-2466-12-52)

Tappin, D.M. et al. (2012) The cessation in pregnancy incentives trial (CPIT): study protocol for a randomized controlled trial. Trials, 13 (113). ISSN 1745-6215 (doi:10.1186/1745-6215-13-113)

2011

McLean, R.C., Briggs, A.H., Slack, R., Zamvar, V., Berg, G.A., El-Shafei, H., Oldroyd, K.G, and Pell, J.P. (2011) Perioperative and long-term outcomes following aortic valve replacement: a population cohort study of 4124 consecutive patients. European Journal of Cardio-Thoracic Surgery, 40 (6). pp. 1508-1514. ISSN 1010-7940 (doi:10.1016/j.ejcts.2011.01.088)

Boyd, K.A., Briggs, A.H., Fenwick, E., Norrie, J., and Stock, S. (2011) Power and sample size for cost-effectiveness analysis: fFN neonatal screening. Contemporary Clinical Trials, 32 (6). pp. 893-901. ISSN 1551-7144 (doi:10.1016/j.cct.2011.07.007)

Barton, P., Andronis, L., Briggs, A., McPherson, K., and Capewell, S. (2011) Effectiveness and cost effectiveness of cardiovascular disease prevention in whole populations: modelling study. British Medical Journal, 343 . d4044-d4044. ISSN 0959-535X (doi:10.1136/bmj.d4044)

Govan, L. et al. (2011) Achieved levels of HbA1c and likelihood of hospital admission in people with type 1 diabetes in the Scottish population: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetes Care, 34 (9). pp. 1992-1997. ISSN 0149-5992 (doi:10.2337/dc10-2099)

Macpherson, K.J. et al. (2011) Trends in incidence and in short term survival following a subarachnoid haemorrhage in Scotland, 1986 - 2005: a retrospective cohort study. BMC Neurology, 11 (1). p. 38. ISSN 1471-2377 (doi:10.1186/1471-2377-11-38)

Price, M.J., Welton, N.J., Briggs, A.H., and Ades, A.E. (2011) Model averaging in the presence of structural uncertainty about treatment effects: influence on treatment decision and expected value of information. Value in Health, 14 (2). pp. 205-218. ISSN 1098-3015 (doi:10.1016/j.jval.2010.08.001)

Starkie, H.J., Briggs, A.H., Chambers, M.G., and Jones, P. (2011) Predicting EQ-5D Values Using the SGRQ. Value in Health, 14 (2). pp. 354-360. ISSN 1098-3015 (doi:10.1016/j.jval.2010.09.011)

Bauld, L., Boyd, K. A., Briggs, A. H., Chesterman, J., Ferguson, J., Judge, K., and Hiscock, R. (2011) One-Year Outcomes and a Cost-Effectiveness Analysis for Smokers Accessing Group-Based and Pharmacy-Led Cessation Services. Nicotine and Tobacco Research, 13 (2). pp. 135-145. ISSN 1462-2203 (doi:10.1093/ntr/ntq222)

Bousquet, J. et al. (2011) How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA²LEN statement. Allergy, 66 (6). pp. 765-774. ISSN 0105-4538 (doi:10.1111/j.1398-9995.2011.02590.x)

Boyd, K.A., Briggs, A., Paul, J., Iveson, T., Midgely, R., Harkin, A., Bates, G., Alexander, L., and Cassidy, J. (2011) Analysis of adverse events and quality of life data for an economic evaluation of adjuvant chemotherapy in colorectal cancer: when can we stop collecting? Trials, 12 . A41. ISSN 1745-6215 (doi:10.1186/1745-6215-12-S1-A41)

Cummins, E., Asseburg, C., Punekar, Y.S., Shore, E., Morris, J., Briggs, A., and Fenwick, E.L. (2011) Cost-effectiveness of infliximab for the treatment of active and progressive psoriatic arthritis. Value in Health, 14 (1). pp. 15-23. ISSN 1098-3015 (doi:10.1016/j.jval.2010.10.016 )

Govan, L. et al. (2011) Inpatient costs for people with type 1 and type 2 diabetes in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia, 54 (8). pp. 2000-2008. ISSN 0012-186X (doi:10.1007/s00125-011-2176-7)

2010

Boyd, K.A., Fenwick, E., and Briggs, A. (2010) Using an iterative approach to economic evaluation in the drug development process. Drug Development Research, 71 (8). pp. 470-477. ISSN 0272-4391 (doi:10.1002/ddr.20421)

Mihaylova, B., Briggs, A., O'Hagan, A., and Thompson, S.G. (2010) Review of statistical methods for analysing healthcare resources and costs. Health Economics, 20 (8). pp. 897-916. ISSN 1057-9230 (doi:10.1002/hec.1653)

Briggs, A.H., Glick, H., Lozano-Ortega, G., Spencer, M., Calverley, P., Jones, P., and Vestbo, J. (2010) Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study. European Respiratory Journal, 35 (3). pp. 532-539. ISSN 0903-1936 (doi:10.1183/09031936.00153108)

Briggs, A., Ritchie, K., Fenwick, E., Chalkidou, K., and Littlejohns, P. (2010) Access with evidence development in the UK past experience, current initiatives and future potential. PharmacoEconomics, 28 (2). pp. 163-170. ISSN 1170-7690 (doi:10.2165/11531410-000000000-00000)

Lorgelly, P.K. et al. (2010) An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial. European Journal of Heart Failure, 12 (1). pp. 66-74. ISSN 1388-9842 (doi:10.1093/eurjhf/hfp172)

Briggs, A.H. (2010) Transportability of comparative effectiveness and cost-effectiveness between countries. Value in Health, 13 . S22-S25. ISSN 1098-3015 (doi:10.1111/j.1524-4733.2010.00751.x)

Campbell, H.E., Gray, A.M., Harris, A.L., Briggs, A.H., and Taylor, M.A. (2010) Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK. British Journal of Cancer, 103 (6). pp. 776-786. ISSN 0007-0920 (doi:10.1038/sj.bjc.6605863)

Crott, R., and Briggs, A. (2010) Mapping the QLQ-C30 quality of life cancer questionnaire to EQ-5D patient preferences. European Journal of Health Economics, 11 (4). pp. 427-434. ISSN 1618-7598 (doi:10.1007/s10198-010-0233-7)

Dolan, G.P., Stone, D.H., and Briggs, A. (2010) A systematic review of continuous performance task research in children prenatally exposed to alcohol. Alcohol and Alcoholism, 45 (1). pp. 30-38. ISSN 0735-0414 (doi:10.1093/alcalc/agp062)

Hollingworth, W., Campbell, J.D., Kowalski, J., Ravelo, A., Girod, I., Briggs, A., and Sullivan, S.D. (2010) Exploring the impact of changes in neurogenic urinary incontinence frequency and condition-specific quality of life on preference-based outcomes. Quality of Life Research, 19 (3). pp. 323-331. ISSN 0962-9343 (doi:10.1007/s11136-010-9590-z)

Johnston, K.M., Levy, A.R., Lima, V.D., Hogg, R.S., Tyndall, M.W, Gustafson, P., Briggs, A.H., and Montaner, J.S. (2010) Expanding access to HAART: a cost-effective approach for treating and preventing HIV. AIDS, 24 (12). pp. 1929-1935. ISSN 0269-9370 (doi:10.1097/QAD.0b013e32833af85d)

Langhorne, P. et al. (2010) Estimating the impact of stroke unit care in a whole population: an epidemiological study using routine data. Journal of Neurology, Neurosurgery and Psychiatry, Advanc . ISSN 0022-3050 (doi:10.1136/jnnp.2009.195131)

Lewsey, J. et al. (2010) Temporal trends in hospitalisation for stroke recurrence following incident hospitalisation for stroke in Scotland. BMC Medicine, 8 (23). ISSN 1741-7015 (doi:10.1186/1741-7015-8-23)

Lorgelly, P.K., Lawson, .D., Fenwick, E.A.L., and Briggs, A.H. (2010) Outcome Measurement in Economic Evaluations of Public Health Interventions: a Role for the Capability Approach? International Journal of Environmental Research and Public Health, 7 (5). pp. 2274-2289. ISSN 1660-4601 (doi:10.3390/ijerph7052274)

2009

Levy, A., Harrigan, B., Johnston, K., and Briggs, A. (2009) Comparative effectiveness research through the looking glass. Medical Decision Making, 29 (6). NP6-NP8. ISSN 0272-989X (doi:10.1177/0272989X09351590)

Wu, O., Levy, A.R., Briggs, A., Lewis, G., and Jardine, A. (2009) Acute rejection and chronic nephropathy: a systematic review of the literature. Transplantation, 87 (9). pp. 1330-1339. ISSN 0041-1337 (doi:10.1097/TP.0b013e3181a236e0)

Boyd, K.A., and Briggs, A.H. (2009) Cost-effectiveness of pharmacy and group behavioural support smoking cessation services in Glasgow. Addiction, 104 (2). pp. 317-325. ISSN 0965-2140 (doi:10.1111/j.1360-0443.2008.02449.x)

Briggs, A., Starkie, H., and Wu, O. (2009) Health economics in asthma and COPD. In: Barnes, P.J., Drazen, J.M., Rennard, S.I. and Thomson, N.C. (eds.) Asthma and COPD. Academic Press/Elsevier,, London, pp. 751-760. ISBN 9780123740014

Jacobs-van der Bruggen, M.A.M., van Baal, P.H., Hoogenveen, R.T., Feenstra, T.L., Briggs, A.H., Lawson, K., Feskens, E.J.M., and Baan, C.A. (2009) Cost-effectiveness of lifestyle modification in diabetes patients. Diabetes care, 32 (8). pp. 1453-1458. ISSN 0149-5992 (doi:10.2337/dc09-0363 )

Levy, A.R., Szabo, S., Briggs, A., Pleil, A., Davie, A., Zlateva, G., and Javitt, J. (2009) Joint Assessment of Intended and Unintended Effects of Medications: An Example Using Vascular Endothelial Growth Factor Inhibitors for Neovascular Age-Related Macular Degeneration. Journal of Ophthalmology, 2009 . p. 540431. ISSN 2090-004X (doi:10.1155/2009/540431)

Levy, A.R., Szabo, S., Briggs, A., Pleil, A., Davie, A., Zlateva, G., and Javitt, J. (2009) Joint Assessment of Intended and Unintended Effects of Medications: An Example Using Vascular Endothelial Growth Factor Inhibitors for Neovascular Age-Related Macular Degeneration. Journal of Ophthalmology, 2009 . ISSN 2090-004X (doi:10.1155/2009/540431)

Lewsey, J. et al. (2009) Age- and sex-specific trends in fatal incidence and hospitalized incidence of stroke in Scotland, 1986 to 2005. Circulation: Cardiovascular Quality and Outcomes, 2 . pp. 475-483. ISSN 1941-7713 (doi:10.1161/CIRCOUTCOMES.108.825968)

Lewsey, J.D. et al. (2009) Sex differences in incidence, mortality, and survival in individuals with stroke in Scotland, 1986 to 2005. Stroke, 40 (4). pp. 1038-1043. ISSN 0039-2499 (doi:10.1161/STROKEAHA.108.542787)

Mihaylova, B., Briggs, A., Hlatky, M., Armitage, J., Parish, S., Gray, A., and Collins, R. (2009) Statin cost-effectiveness in the United States for people at different vascular risk levels. Circulation: Cardiovascular Quality and Outcomes, 2 (2). pp. 65-72. ISSN 1941-7713 (doi:10.1161/CIRCOUTCOMES.108.808469)

2008

Briggs, A.H., Spencer, M., Wang, H., and Mannino, D. (2008) Development and validation of a prognostic index for health outcomes in chronic obstructive pulmonary disease. Archives of Internal Medicine, 168 (1). pp. 71-79. ISSN 0003-9926 (doi:10.1001/archinternmed.2007.37)

Barton, G.R., Briggs, A.H., and Fenwick, E.A.L. (2008) Optimal Cost-Effectiveness Decisions: The Role of the Cost-Effectiveness Acceptability Curve (CEAC), the Cost-Effectiveness Acceptability Frontier (CEAF), and the Expected Value of Perfection Information (EVPI). Value in Health, 11 (5). pp. 886-897. ISSN 10983015 (doi:10.1111/j.1524-4733.2008.00358.x)

Briggs, A., Wild, D., Lees, M., Reaney, M., Dursun, S., Parry, D., and Mukherjee, J. (2008) Impact of schizophrenia and schizophrenia treatment related adverse events on quality of life: direct utility elicitation. Health and Quality of Life Outcomes, 6 (105). pp. 1-9. ISSN 1477-7525 (doi:10.1186/1477-7525-6-105)

Claxton, K., Briggs, A.H., Buxton, M.J., Culyer, A.J., McCabe, C., Walker, S., and Sculpher, M.J. (2008) Value based pricing for NHS drugs: an opportunity not to be missed? British Medical Journal, 336 (7638). pp. 251-254. ISSN 0959-535X (doi:10.1136/bmj.39434.500185.25)

Eckerman, S., Briggs, A., and Willan, A.R. (2008) Health technology assessment in the cost-disutility plane. Medical Decision Making, 28 (2). pp. 172-181. ISSN 0272-989X (doi:10.1177/0272989X07312474)

Hirst, A., Dutton, S., Wu, O., Briggs, A., Edwards, C., Waldenmaier, L., Maresh, M., Nicholson, A., and McPherson, K. (2008) The HOPEFUL Study: a multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation (UAE) for the treatment of symptomatic uterine fibroids. Health Technology Assessment, 123 (5). pp. 1-248. ISSN 1366-5278

Hirst, A., Dutton, S., Wu, O., Briggs, A., Edwards, C., Waldenmaier, L., Maresh, M., Nicholson, A., and McPherson, K. (2008) A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study. Health Technology Assessment (Winchester, England), 12 (5). 1-227, xi. ISSN 1366-5278 (doi:10.3310/hta12050)

Levy, A.R., Kowdley, K., Iloeje, U.H., Tafesse, E., Mukherjee, J., Gish, R., Bzowej, N., and Briggs, A.H. (2008) The impact of chronic hepatitis B on quality of life: a multinational study of utilities from infected and uninfected person. Value in Health, 11 (3). pp. 527-538. ISSN 1098-3015 (doi:10.1111/j.1524-4733.2007.00297.x)

Starkie, H., Briggs, A.H., and Chamber, M.G. (2008) Pharmacoeconomics in COPD: lessons for the future. Interntaional Journal of COPD, 3 (1). pp. 71-88.

2007

Campbell, H., Briggs, A.H., Buxton, M., Kim, L., and Thompson, S. (2007) The credibility of health economic models for health policy decision-making: the case of population screening for abdominal aortic aneurysm. Journal of Health Services Research and Policy, 12 (1). pp. 11-17. ISSN 1355-8196 (doi:10.1258/135581907779497594)

Briggs, AH et al. (2007) Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study. Heart, 93 (9). pp. 1081-1086.

Campbell, H, Briggs, AH, Buxton, M, Kim, L, and Thompson, S (2007) The credibility of health economic models for health policy decision-making: the case of population screening for abdominal aortic aneurysm. Journal of Health Services Research and Policy, 12 (1). pp. 11-17. (doi:10.1258/135581907779497594)

Culyer, A., McCabe, C., Briggs, A.H., Claxton, K., Buxton, M., Akehurst, R., Sculpher, M.J., and Brazier, J. (2007) Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical Excellence. Journal of Health Services Research and Policy, 12 (1). pp. 56-58.

Kim, LG, Thompson, SG, Briggs, AH, Buxton, MJ, and Campbell, H (2007) How cost-effective is screening for abdominal aortic aneurysms? Journal of Medical Screening, 14 (1). pp. 46-52.

Luc, G, Ades, AE, Sutton, AJ, Cooper, NJ, BriggS, AH, and Caldwell, DM (2007) Meta-analysis of mixed treatment comparisons at multiple follow-up times. Statistics in Medicine, 26 . pp. 3681-3699. (doi:10.1002/sim.2831)

Ossa, D.F., Briggs, A.H., McIntosh, E., Cowell, W., Littlewood, T., and Sculpher, M.J. (2007) Recombinant erythropoietin for chemotherapy-related anaemia: economic value and health-related quality-of-life assessment using direct utility elicitation and discrete choice experiment methods. PharmacoEconomics, 25 (3). pp. 223-237. ISSN 1170-7690

2006

Mihaylova, B., Briggs, A.H., Armitage, J., Parish, S., Gray, A., and Collins, R. (2006) Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20,536 people. British Medical Journal, 333 (7579). p. 1145. ISSN 0959-535X (doi:10.1136/bmj.38993.731725.BE)

Briggs, A.H., Bousquet, J., Wallace, M., Busse, W.W., Clark, T.J.H., Pedersen, S.E., and Baternan, E.D. (2006) Cost-effectiveness of asthma control: an economic appraisal of the GOAL study. Allergy, 61 (5). pp. 531-536. ISSN 0105-4538 (doi:10.1111/j.1398-9995.2006.01038.x)

Briggs, A.H., and Levy, A.R. (2006) Pharmacoeconomics and pharmacoepidemiology - Curious bedfellows or a match made in heaven? PharmacoEconomics, 24 . pp. 1079-1086. ISSN 1170-7690

Briggs, A.H., Lozano-Ortega, G., Spencer, S., Bale, G., Spencer, M.D., and Burge, S. (2006) Estimating the cost-effectiveness of fluticasone propionate for treating chronic obstructive pulmonary disease in the presence of missing data. Value in Health, 9 (4). pp. 227-235. ISSN 1098-3015 (doi:10.1111/j.1524-4733.2006.00106.x)

Deckers, JW, Goedhart, DM, Boersma, E, Briggs, AH, Bertrand, M, Ferrari, R, Remme, WJ, Fox, K, and imoons, ML (2006) Treatment benefit by perindopril in patients with stable coronary artery disease at different levels of risk. European Heart Journal, 27 . pp. 796-801. (doi:10.1093/eurheartj/ehi809)

Williams, C et al. (2006) Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy. Health Technology Assessment, 10 . 1-+.

2005

Manca, A., Rice, N., Sculpher, M.J., and Briggs, A.H. (2005) Assessing generalisability by location in trial-based cost-effectiveness analysis: the use of multilevel models. Health Economics, 14 (5). pp. 471-485. ISSN 1057-9230 (doi:10.1002/hec.914)

Claxton, K., Sculpher, M., McCabe, C., Briggs, A.H., Akehurst, R., Buxton, M., Brazier, J., and O'Hagan, T. (2005) Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Economics, 14 (4). pp. 339-347. ISSN 1057-9230 (doi:10.1002/hec.985)

Briggs, A.H. (2005) Probabilistic analysis of cost-effectiveness models: statistical representation of parameter uncertainty. Value in Health, 8 (1). pp. 1-2. ISSN 1098-3015 (doi:10.1111/j.1524-4733.2005.08101.x)

Briggs, A.H., Nixon, R., Dixon, S., and Thompson, S. (2005) Parametric modelling of cost data: some simulation evidence. Health Economics, 14 (4). pp. 421-428. ISSN 1057-9230 (doi:10.1002/hec.941)

Briggs, AH (2005) Probabilistic analysis of cost-effectiveness models: statistical representation of parameter uncertainty. Value in Health, 8 (1). pp. 1-2.

Clarke, PM, Gray, A, Briggs, AH, Stevens, RJ, Matthews, DR, and Holman, RR (2005) Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72). Diabetologia, 48 (5). pp. 868-877.

Gagnon, YM, Levy, AR, Spencer, MD, Hurley, JS, Frost, FJ, Mapel, DW, and Briggs, AH (2005) Economic evaluation of treating chronic obstructive pulmonary disease with inhaled corticosteroids and long-acting beta2-agonists in a health maintenance organization. Respiratory Medicine, 99 (12). pp. 1534-1545.

Manca, A, Rice, N, Sculpher, MJ, and Briggs, AH (2005) Assessing generalisability by location in trial-based cost-effectiveness analysis: the use of multilevel models.[erratum appears in Health Econ. Health Economics, 14 (5). pp. 471-485.

Mihaylova, B, Briggs, AH, Armitage, J, Parish, S, Gary, A, and Collins, R (2005) Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals. Lancet, 365 (9473). pp. 1779-1785.

O'Hagan, T. et al. (2005) Incorporation of uncertainty in health economic modelling studies. PharmacoEconomics, 23 (6). pp. 529-536. ISSN 1170-7690

Ramsey, S et al. (2005) Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. Value in Health, 8 (5). pp. 521-533.

Reed, S et al. (2005) Conducting economic evaluations alongside multinational clinical trials: toward a research consensus. American Heart Journal, 149 (3). pp. 434-443.

Spencer, M.D., Briggs, A.H., Grossman, R.J., and Rance, L. (2005) Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease. PharmacoEconomics, 23 (6). pp. 619-637. ISSN 1170-7690

2004

Clarke, P.M., Gray, A.M., Briggs, A., Farmer, A.J., Fenn, P,, Stevenson, R.J., Matthews, D.R., Stratton, I.M., and Holman, R.R. (2004) A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia, 47 (10). pp. 1747-1759. ISSN 1432-0428 (doi:10.1007/s00125-004-1527-z)

Briggs, A.H. (2004) Statistical approaches to handling uncertainty in health economic evaluation. Psychiatrist, 16 (6). pp. 551-561. ISSN 1758-3209

Briggs, AH (2004) Statistical approaches to handling uncertainty in health economic evaluation. [29 refs]. European Journal of Gastroenterology and Hepatology, 16 (6). pp. 551-561. ISSN 0954-691X

Briggs, AH, Sculpher, MJ, Dawson, J, Fitzpatrick, R, Murray, D, and Malchau, H (2004) The Use of Probabilistic Decision Models in Technology Assessment: The Case of Total Hip Replacement. Applied Health Economics and Health Policy, 3 (2). pp. 78-79.

Clarke, PM, Gray, A, Briggs, AH, Farmer, AJ, Fenn, P, Stevens, RJ, Matthews, DR, Stratton, IM, and Holman, R (2004) A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia, 47 . pp. 1747-1759. (doi:10.1007/s00125-004-1527-z)

Gagnon, YM, Levy, AR, Iloeje, UH, and Briggs, AH (2004) Treatment costs in Canada of health conditions resulting from chronic Hepatitis B infection. Journal of Clinical Gastroenterology, 38 (Suppl ). S179-S186.

Willan, A, Briggs, AH, and Hoch, JS (2004) Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data. Health Economics, 13 (5). pp. 461-475.

2003

Clarke, P., Gray, A., Legood, R., Briggs, A., and Holman, R. (2003) The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65). Diabetic Medicine, 20 (6). pp. 442-450. ISSN 0742-3071 (doi:10.1046/j.1464-5491.2003.00972.x)

Reed, S.D., Dillingham, P.W., Briggs, A.H., Veestra, D.L., and Sullivan, S.D. (2003) A Bayesian approach to aid in formulary decision making: incorporating institution-specific cost-effectiveness data with clinical trial results. Medical Decision Making, 23 (3). pp. 252-264. ISSN 0272-989X (doi:10.1177/0272989X03023003007)

Briggs, AH, Ades, AE, and Price, MJ (2003) Probabilistic sensitivity analysis for decision trees with multiple branches: use of the Dirichlet distribution in a Bayesian framework. Medical Decision Making, 23 (4). pp. 341-350.

Briggs, AH, Clark, T, Wolstenholme, J, and Clark, PM (2003) Missing ... presumed at random: cost analysis of incomplete data. Health Economics, 12 (5). pp. 377-393.

Craig, D. et al. (2003) New BMJ policy on economic evaluations. Economic evaluations should be judged on economic merit. British Medical Journal, 326 (7386). p. 445. ISSN 0959-535X

Hoch, JS, Briggs, AH, and Willan, AR (2003) Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis. Health Economics, 11 (5). pp. 415-430.

Hope, A, and Briggs, AH (2003) Concerns regarding the ISPOR Code of Ethics for Researchers. Value in Health, 7 (4). pp. 510-511.

Tytgat, GN, Heading, RC, Muller-Lissner, S, Kamm, MA, Scholmerich, J, Berstad, A, Fried, M, Chaussade, S, Jewell, D, and Briggs, AH (2003) Contemporary understanding and management of reflux and constipation in the general population and pregnancy: a consensus meeting. Alimentary Pharmacology and Therapeutics, 18 (3). pp. 291-301. ISSN 0269-2813 (doi:10.1046/j.1365-2036.2003.01679.x)

2002

Briggs, A., Clark, T., Wolstenholme, J., and Clarke, P. (2002) Missing.... presumed at random: cost-analysis of incomplete data. Health Economics, 12 (5). pp. 377-392. ISSN 1057-9230 (doi:10.1002/hec.766)

O'Brien, B.J., and Briggs, A.H. (2002) Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods. Statistical Methods in Medical Research, 11 (6). pp. 455-468. ISSN 0962-2802 (doi:10.1191/0962280202sm304ra)

Briggs, A.H., O'Brien, B.J., and Blackhouse, G. (2002) Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies. Annual Review of Public Health, 23 . pp. 377-401. ISSN 0163-7525 (doi:10.1146/annurev.publhealth.23.100901.140534)

Blackhouse, G., Briggs, A., and O'Brien, B.J. (2002) A note on the estimation of confidence intervals for cost-effectiveness when costs and effects are censored. Medical Decision Making, 22 (2). pp. 173-177. ISSN 0272-989X (doi:10.1177/02729890222063053)

Blackhouse, G, Briggs, AH, and O'Brien, BJ (2002) Estimation of confidence intervals for cost-effectiveness when costs and effects are censored. Medical Decision Making, 22 . pp. 170-174.

Blackhouse, G, Briggs, AH, and O'Brien, BJ (2002) A note on the estimation of confidence intervals for cost-effectiveness when costs and effects are censored. Medical Decision Making, 22 (2). pp. 173-177.

Briggs, A.H., Goeree, R., Blackhouse, G., and O'Brien, B.J. (2002) Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease. Medical Decision Making, 22 (4). pp. 290-308. ISSN 0272-989X (doi:10.1177/027298902400448867)

Briggs, AH, Goeree, R, and O'Brien, BJ (2002) Probabilistic analysis of models: choosing between treatment strategies for gastroesophageal reflux disease. Medical Decision Making, 22 (4). pp. 290-308.

Briggs, AH, O'Brien, BJ, and Blackhouse, G (2002) Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies. Annual Review of Public Health, 23 . pp. 377-401.

Goeree, R, O'Brien, BJ, Blackhouse, G, Marshall, J, Briggs, AH, and Lad, R (2002) Cost-effectiveness and cost-utility of long-term management strategies for heartburn. Value in Health, 5 (4). pp. 312-328.

O'Brien, BJ, and Briggs, AH (2002) Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods. Statistical Methods in Medical Research, 11 (6). pp. 455-468.

Price, M.J., and Briggs, A.H. (2002) Development of an economic model to assess the cost effectiveness of asthma management strategies. PharmacoEconomics, 20 (3). pp. 183-194. ISSN 1170-7690

2001

Sendi, P.P., and Briggs, A.H. (2001) Affordability and cost-effectiveness: decision-making on the cost-effectiveness plane. Health Economics, 10 (7). pp. 675-680. ISSN 1057-9230 (doi:10.1002/hec.639)

Briggs, A.H., and O'Brien, B.J. (2001) The death of cost-minimization analysis? Health Economics, 10 (2). pp. 179-184. ISSN 1057-9230 (doi:10.1002/hec.584)

Briggs, A. (2001) A Bayesian approach to stochastic cost-effectiveness analysis. International Journal of Technology Assessment in Health Care, 17 (1). pp. 69-82. ISSN 0266-4623

Briggs, AH (2001) A Bayesian approach to stochastic cost-effectiveness analysis. An illustration and application to blood pressure control in type 2 diabetes. International Journal of Technology Assessment in Health Care, 17 (1). pp. 69-82.

Briggs, AH, and O'Brien, BJ (2001) The death of cost-minimization analysis?. [23 refs]. Health Economics, 10 (2). pp. 179-184.

Briggs, AH, and Tambour, M (2001) The design and analysis of stochastic cost-effectiveness studies for the evaluation of health care interventions. Drug Information Journal, 35 (4). pp. 1455-1468.

Delaney, B.C., Wilson, S.L., Roalfe, A., Briggs, A.H., and Hobbs, F.D.R. (2001) Empirical treatment or prompt endoscopy? - author's reply. Lancet, 357 . p. 1366. ISSN 0140-6736 (doi:10.1016/S0140-6736(00)04492-5)

Glick, HA, and Briggs, AH (2001) Cost-effectiveness of health care interventions: a guide to quantifying stochastic uncertainty and presenting the result of cost-effectiveness analyses. Expert Reviews in Pharmacoeconomics and Outcomes Research, 1 (1). pp. 25-36.

Levy, AR, Briggs, AH, Demers, C, and O'Brien, BJ (2001) Cost-effectiveness of beta-blocker therapy with metoprolol or with carvedilol for treatment of heart failure in Canada. American Heart Journal, 142 (3). pp. 537-543.